›Publications›Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Auteurs : Decazes P, Ammari S, De Prévia A, Mottay L, Lawrance L, Belkouchi Y, Benatsou B, Albiges L, Balleyguier C, Vera P, Lassau N. Revue : Diagnostics (Basel) Année : 2023 Groupe : QuantIF ← Retour aux publications